Polio Inccreased 50-80% Following Introduction of the Polio Vaccine!
In 1962, Dr. Bernard Greenberg, Biostatistics Dept. Head at the University of North Carolina School of Public Health, testified before Congress that cases of polio increased substantially after the first polio vaccine was introduced - 50% from 1957-58, and 80% from 1958-59 - and that the Public Health Service deliberately manipulated statistics to give the opposite impression. Source: Natural News
FDA: Politics, Conflicts of Interest and Outright Corruption
"The FDA is riddled with politics, conflicts of interest and outright corruption, with data manipulation and harassment of whistleblowers." - Money Watch, March 10, 2010. "The FDA is the best agency the pharmaceutical industry can buy. The agency is lurching from one disaster to the next; one shocking lapse after another." - From the article "Can We Trust The FDA?", Readers Digest, April 2008.
RFK Jr: CDC is a Subsidiary of the Pharmaceutical Industry
The CDC is a subsidiary of the pharmaceutical industry. The agency owns more than 20 vaccine patents and purchases and sells $4.1 billion in vaccines annually. Congressman Dave Weldon has pointed out that the primary metric for success across the CDC is how many vaccines the agency sells and how successfully the agency expands its vaccine program—regardless of any negative effects on human health... The scientists in that part of the agency should no longer be considered part of the public safety sector. Their function is to promote vaccines. As Dr. Thompson has attested, they are routinely ordered to destroy, manipulate and conceal evidence of adverse vaccine reactions in order to protect that ultimate metric. The CDC should not be the agency that we are relying on for oversight of the vaccine program. It’s the wolf guarding the hen house. It’s not just the CDC. Virtually all the institutions that are supposed to stand between a rapacious industry and vulnerable children have been compromised... Congress, the regulatory agencies, FDA, CDC, IOM, NIH, AAP, the science journals, the university science departments and the press. More
Drug Companies & Doctors: A Story of Corruption
"It is simply no longer possible to believe much of the clinical research that is published, or to rely on the judgment of trusted physicians or authoritative medical guidelines. I take no pleasure in this conclusion, which I reached slowly and reluctantly over my two decades as an editor of The New England Journal of Medicine.” "No one knows the total amount provided by drug companies to physicians, but I estimate from the annual reports of the top 9 U.S.-based drug companies that it comes to tens of billions of dollars a year in North America alone. By such means, the pharmaceutical industry has gained enormous control over how doctors evaluate and use its own products. Its extensive ties to physicians, particularly senior faculty at prestigious medical schools, affect the results of research, the way medicine is practiced, and even the definition of what constitutes a disease." - Marcia Angell, MD
Book review: Drug Companies & Doctors: A Story of Corruption See also: The Ethical Nag
"Over the paat two decades the pharmaceutical industry has moved very far from its original high purpose of discovering and producing useful new drugs. Now primarilya marketing machine to sell drugs of dubious benefit this industry uses its wealth and power to co-opt every institution that might stand in its way, including the US Congress, the FDA, academic medical centers, and the medical profession itself." -Dr Marcia Angell, MD
Side Effects: Death - Confessions of a Pharma-Insider
Dr John Rengen Virapen, former Eli Lilly executive confesses that he bribed the Swedish government to approve Prozac, in order to advance his career at Eli Lilly. Now that he has retired and has a son of his own, he is working to fight mandatory vaccinations in Germany. All this and more is covered in his book: Side Effects: Death - Confessions of a Pharma-Insider.
See also Gwen Olsen's book: Confessions of an Rx Drug Pusher. The $20 billion in civil and criminal penalties that Big Pharma has paid over the past 20 years is simply written off as "the cost of doing business."
Articles on Fraud in Journal Publishing and Peer Review
- Lead on the 1999 Congressional Investigation into Vaccine Injury Speaks on CDC Fraud
- Jon Rappaport interview: Dr Mark Randall, Former Vaccine Developer Bombshell Exposure of the Vaccine Industry from an Insider!
- Dr Russell Blaylock's article: The Truth Behind the Vaccine Cover-Up What Happened at the Top Secret Simpsonwood Conference!
- Former editor of the BMJ: Peer Review: A Flawed Process at the Heart of Science and Journals
- Robert F Kennedy, Jr: CDC Owns Over 20 Vaccine Patents, Makes $4.1 Billion/Year On Vaccines
- Former editor of the BMJ: Deadly Medicines and Organised Crime: Is the Pharmaceutical Industry Like the Mafia?
- ProPublica report: The Medical System is Now the Leading Cause of Death in the U.S.
- HealthImpactNews article: Senior Nursing Student Dismissed After Objecting to Instructors Promoting Manipulation and Misleading Information to Coerce Parents that Deny Vaccines
- NY Times: Harvard Medical School in Ethics Quandary Over Professors' Ties to Big Pharma
- BMJ: FDA Official Says "The Clinical Trial System is Broken"
- Nature: Publishing: The Peer-Review Scam
- The Scientist: How to Fix Peer Review
- Professor Bruce G. Charlton: Truthfulness in science should be an iron law, not a vague aspiration
- Drug Injury Watch: The Tale of Merck's Fake Medical Journal
- Susan Posel (Dec 13, 2012): Obama Revision to FOIA Rules Keeps Evidence of Vaccine Dangers From Public
- The Denver Post Investigations: Drug firms used dangerous tactics to drive sales to treat kids
- GreenMedInfo: 'Evidence-Based' Medicine: A Coin's Flip Worth of Certainty
- Mercola: Conflicts of Interest Rampant Among FDA Advisors, Study Shows
- Former editor of the BMJ: Medical Research Still a Scandal
- How evidence-based medicine is failing due to biased trials and selective publication
- Not Conducted, but Concocted: Tamiflu Study Written by Ghostwriters Paid by Pharmaceutical Company
- Exposed: 90% of Peer-Reviewed Vaccine Safety Studies Fraudulent; Putting Your Child At Risk
- Dr David Lewis, PhD: The Need for Independent Safety Studies Not Sponsored by Vaccine Makers
- MD$ on the Take: My Career-Ending Expose
- Censored from HuffPost: Vaccines Are Totally Safe Say the People Who Brought us Vioxx, Bextra, Baycol, Trovan, Phen-Fen, Xarelto, Raxar, Avandia, Darvon, Seldane...
Brandy Vaughn: Merck Whistleblower: Silent No More
NIH Blocks Two Doctors From Speaking Out to Investigators
The National Institutes of Health, the U.S. government’s premier health research agency, is refusing to allow two of its doctors to respond to government investigators looking into the quality of a continuing clinical trial of new blood-infection treatments on thousands of patients, according to NIH documents and multiple interviews. The resulting tensions within the NIH have pitted the office of the agency’s director, Francis Collins, against an internal NIH committee of 24 scientists, who are raising questions over the freedom researchers are afforded to critique the work of colleagues. That freedom has long been a crucial form of quality control in the safe development of new medicines and therapies. Barring doctors from commenting on a safety inquiry curtails that freedom, the committee contends. The NIH director’s office maintains that the decision to keep the researchers from talking with investigators concerns choosing the right people to speak for the organization, not scientists’ freedom to critique.
Behind the standoff is a multiyear clinical trial to be completed in 2021, a test of new procedures to treat the often-lethal bloodstream infection known as sepsis, which affects more than a million Americans each year. The trial, funded by the NIH, is known as the Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis trial, or Clovers, and involves testing two treatment approaches on some 2,320 patients. A clinical trial typically benchmarks a new treatment against an existing one, allowing researchers to assess whether the new approach improves outcomes, has little impact, or makes things worse. But, among other issues, the Clovers trial didn’t adequately compare the new treatment against accepted methods, raising red flags, according to critics of the trial.
At the center of the clash are two NIH doctors, Charles Natanson and Peter Eichacker, both of whom have published frequently on the topic of sepsis, medical research and critical-care medicine. Last year, they raised concerns about the way the sepsis study was being conducted, resulting in a critical report on the trial by the nonpartisan consumer group Public Citizen. The group said the Clovers study “predictably will expose many subjects to dangerous deviations from critical care.” That publication caught the attention of the Office for Human Research Protections, a federal agency mandated with assuring American patients aren’t harmed in clinical research. The OHRP launched a federal review of the conduct of the clinical trial, and sought to interview Drs. Natanson and Eichacker. NIH Director Collins’s top assistant, Principal Deputy Director Lawrence A. Tabak, confirmed he prohibited the two doctors from answering questions from OHRP investigators. The Council of the Assembly of Scientists, an internal NIH committee of 24 doctors and researchers representing the scientists on the NIH campus, wrote in a memo to Dr. Tabak that they were “extremely concerned” that the two doctors “have been forbidden by NIH leadership to respond to OHRP, either as an official duty activity or an outside activity.” Continued in next column: "Sepsis: Little Known, but Deadly"
Sepsis: Little Known, but Deadly
It is an infection of the bloodstream, often arising from infections like pneumonia; infections of the stomach or colon, or other infections. Can follow surgery. It is a likely diagnosis when someone develops a high fever suddenly. Can lead to chills, weakness, nausea, vomiting and diarrhea. Most people recover from the milder form, but the death rate is about 40% if it progresses to septic shock. In septic shock, blood vessels dilate and become leaky. Blood pressure plummets. Also in septic shock, internal organs, such as the lungs, kidneys and liver can fail. An estimated 270,000 annually in the U.S. die from sepsis. Sources: Merck Manual, Mayo Clinic, Sepsis Alliance
Dr. Collins, the NIH director who is also a well-known geneticist, declined to comment. His assistant, Dr. Tabak, who ordered the blocking of the two doctors’ testimony, said: “The agency has the responsibility to choose people to respond on behalf of the NIH. This has nothing to do with freedom of speech.” He said Dr. Collins was aware of the decision.
James Kiley of the NIH’s National Heart, Lung, and Blood Institute, which oversees the study, said, “This protocol was developed through a deliberative process and underwent multiple external, independent reviews.” All “found the scientific question important and the approach ethical,” he said.
The two doctors said they were prevented from commenting for this article. OHRP Director Jerry Menikoff declined to comment. The National Institutes of Health, a collection of 27 institutes and centers focusing on all aspects of human health, is the world’s leading funder of medical research, with a budget of $39 billion annually. Most of that money is allocated as grants to academic institutions around the U.S.
Funding a clinical trial like Clovers is a core part of the mission of the NIH to help drive progress toward new treatments of diseases like sepsis. A fundamental ethical concern is how to balance the potential long-term benefits of such clinical research against the immediate risks to the human subjects of the test.
One university, the Washington University School of Medicine, in St. Louis, declined to participate in the Clovers study for some of the same reasons cited by Drs. Natanson and Eichacker, according to a person familiar with the issue and email correspondence reviewed by The Wall Street Journal. Washington University confirmed it had declined to participate, but didn’t specify why.
The Clovers trial continues, encompassing about 50 hospitals, although the protocol for the study has changed somewhat. The two doctors are still troubled by the study methodology making it more imperative they speak with OHRP officials, people familiar with the issue say. Continued in next column: "Sepsis Treatment Trial at NIH"
Sepsis Treatment Trial at NIH
Sepsis is an infection of the bloodstream that results from simpler infections, like pneumonia, urinary-tract infections or even skin infections. By the time sepsis worsens into the more dire septic shock, it causes death in about 40% of cases. An estimated 270,000 U.S. sepsis cases end in death each year. In severe sepsis, blood pressure plummets. Internal organs shut down. Standard treatment includes antibiotics, fluids and drugs to support blood pressure.
The trial seeks to test two approaches to sepsis care, one that emphasizes early blood-pressure medicine and the other offering extensive fluids. But the study’s protocol didn’t compare those methods to the standard protocols for sepsis treatment, Public Citizen said.
“The trial includes two experimental groups that each involve strategies for the early management of severe sepsis that to our knowledge have never been tested previously in any clinical trial,” said Public Citizen in its report.
The issue came to a head two months ago around an NIH conference table, with a half-dozen of the 24 senior scientists and senior NIH officials, including Dr. Tabak, convening to discuss the underlying issues like research freedom of speech. Dr. Tabak repeatedly contended that Dr. Natanson’s and Dr. Eichacker’s actions and commentary were inappropriate, according to people present at the meeting.
Now, with OHRP evaluating the study, said Michael Carome, director of Public Citizen’s Health Research Group, the official NIH stance is particularly unacceptable. “These two doctors have identified what we think is a serious problem,” he said, adding that the OHRP “should take a precautionary approach. They should stop the trial.” Source
Death of CDC Epidemiolgist Dr Tim Cunningham Highly Suspicious
Epidemiolgist Dr Tim Cunningham from the CDC said he was concerned that the virus in the influenza vaccine is mutating during the manufacturing process.
Dr Cunningham disappeared from his home in Feb 2018 after telling people he was worried about his safety and telling a neighbour to remove his phone number from their phone. He was found "drowned" in a local river near the CDC on the 6th April 2018.
The Police said in their live interview that it was unusual he had left his home open, phone at home, keys at home, car at home and beloved dog at home. Police also made it clear that they had previously searched the area of river where he was found and found nothing. And yet, CNN reported his death as a suicide. He was a 35 year old US Naval Commander.
Dr Jeffery Bradstreet was also involved in vaccine research. He was found DEAD in a river with a gun shot wound in July 2015. In May 2015 he had said he was about to publish research showing that vaccines cause CANCER by blocking your macrophages. FIVE of his research colleagues died over the next 3 months in FLORIDA USA.
Although media reported that it was suicide, the Coroner found the bullet wound for Dr Bradstreet was NOT self-inflicted. His family has taken legal action against media outlets who reported it as suicide.